Reports for RISPERIDONE
Ingredient
RISPERIDONE
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
SANDOZ RISPERIDONE | 3.0MG | TABLET | Resolved | 2021-09-28 | 2021-10-16 | 146330 |
SANDOZ RISPERIDONE | 3.0MG | TABLET | Resolved | 2022-12-12 | 2022-12-28 | 177938 |
SANDOZ RISPERIDONE | 3MG | TABLET | Resolved | 2023-06-19 | 2023-07-18 | 195422 |
SANDOZ RISPERIDONE | 4.0MG | TABLET | Resolved | 2020-11-16 | 2020-12-15 | 128423 |
RISPERIDONE | 0.25MG | TABLET | Resolved | 2024-03-25 | 2024-05-17 | 223270 |
PMS-RISPERIDONE | 1MG | SOLUTION | Resolved | 2017-05-02 | 2017-06-09 | 8633 |
PMS-RISPERIDONE | 1MG | SOLUTION | Resolved | 2018-01-26 | 2018-04-19 | 37328 |
PMS-RISPERIDONE | 1MG | SOLUTION | Resolved | 2023-10-30 | 2024-03-16 | 208577 |
PRO-RISPERIDONE | 0.25MG | TABLET | Resolved | 2017-09-07 | 2017-11-09 | 21239 |
PRO-RISPERIDONE | 1.0MG | TABLET | Resolved | 2017-08-24 | 2017-09-22 | 20226 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
RISPERDAL | 0.5MG | TABLET | Discontinued | 2018-11-29 | 2019-04-02 | 68098 |
MYLAN-RISPERIDONE | 0.25MG | TABLET | Discontinued | 2017-07-18 | 2018-02-15 | 16154 |
MYLAN-RISPERIDONE | 0.50MG | TABLET | Discontinued | 2017-07-18 | 2018-02-15 | 16157 |
MYLAN-RISPERIDONE | 1.0MG | TABLET | Discontinued | 2017-07-18 | 2017-09-08 | 16160 |
MYLAN-RISPERIDONE | 2.0MG | TABLET | Discontinued | 2017-07-18 | 2017-10-03 | 16163 |
MYLAN-RISPERIDONE | 3.0MG | TABLET | Discontinued | 2017-07-18 | 2017-10-03 | 16166 |
MYLAN-RISPERIDONE | 4.0MG | TABLET | Discontinued | 2017-07-18 | 2017-10-03 | 16169 |
PMS-RISPERIDONE ODT | 3MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2020-06-17 | 2020-06-17 | 118156 |
PMS-RISPERIDONE ODT | 4MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2020-06-17 | 2020-06-17 | 118159 |
PMS-RISPERIDONE ODT | 1MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2020-06-17 | 2020-06-17 | 118150 |